FAQ

Myelomonocytic leukemia

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1962-2018
0204019622018

Related topics

Related topics

2 relations
Eosinophilic leukemia

Broader (1)

Myeloid Leukemia

Related mentions per year

Related mentions per year

1937-2018
19401960198020002020
Myelomonocytic leukemia
Myeloid Leukemia
Eosinophilic leukemia

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
Prognostic score including gene mutations in chronic myelomonocytic leukemia.
PURPOSE Several prognostic scoring systems have been proposed for chronic myelomonocytic leukemia (CMML), a disease in which some… (More)
  • table 2
  • table 1
  • figure 1
  • table 3
  • figure 2
Is this relevant?
Highly Cited
2011
Highly Cited
2011
Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3A.
Chronic myelomonocytic leukemia (CMML), a myelodysplastic/myeloproliferative neoplasm, is characterized by monocytic… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2011
Highly Cited
2011
Cytogenetic risk stratification in chronic myelomonocytic leukemia.
BACKGROUND The prognostic value of cytogenetic findings in chronic myelomonocytic leukemia is unclear. Our purpose was to… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2009
Highly Cited
2009
TET2 gene mutation is a frequent and adverse event in chronic myelomonocytic leukemia.
BACKGROUND Acquired somatic deletions and loss-of-function mutations in one or several codons of the TET2 (Ten-Eleven… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
Is this relevant?
2007
2007
Activity of decitabine, a hypomethylating agent, in chronic myelomonocytic leukemia.
BACKGROUND Hypomethylating agents have activity in myelodysplastic syndrome (MDS) and have received approval for the treatment of… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia.
The SH2 domain-containing protein-tyrosine phosphatase PTPN11 (Shp2) is required for normal development and is an essential… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
2004
2004
Risk assessment in chronic myelomonocytic leukemia (CMML).
The clinical course of chronic myelomonocytic leukemia (CMML) is extremely variable, and disease progression can occur at any… (More)
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients.
Chronic myelomonocytic leukemia (CMML) is a hematologic malignancy characterized by wide heterogeneity of clinical presentation… (More)
  • table 1
  • table 3
  • table 2
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
1995
Highly Cited
1995
Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia.
Chromosomal rearrangements involving band 12p13 are found in a wide variety of human leukemias but are particularly common in… (More)
Is this relevant?
Highly Cited
1983
Highly Cited
1983
Association of an inversion of chromosome 16 with abnormal marrow eosinophils in acute myelomonocytic leukemia. A unique cytogenetic-clinicopathological association.
We identified 18 patients with an inversion of chromosome 16, inv(16)(p13q22), among 308 patients with newly diagnosed acute… (More)
Is this relevant?